can you combine semaglutide with tirzepatide Maintenance therapy on or Confused about which treatment is

Another recent study points out that genetics can influence as much as 50% of a persons propensity to gain weight and difficulty losing it, with the other 50% coming from environmental factors like diet and exercise.2 So, it makes sense that the medical establishment is finally embracing weight loss drugs as more than just a cosmetic concern

Semaglutide and receptor dynamics in GLP-1 signaling

These approaches have led to significant weight loss with the dual GLP-1/glucagon receptor agonist survodutide (-13.5% with the 6-mg dose at 76 weeks in a phase 3 SYNCHRONIZE-1 trial) [16] , the dual GLP-1 receptor agonist and GIP antagonist Maridebart cafraglutide (known as MariTide) (-12.3% to -16.2% across different doses at 52 weeks in a phase 2 trial) [17] or the triple GLP-1/GIP/glucagon receptor agonist retatrutide (-24.2% with the 12-mg dose at 48 weeks in a phase 2 trial) [18]

Across the 39 companies we reviewed, 87% offered structured wrap-around support, including one or more of the following: Tracking and goal-setting tools Meal plans and recipes Nutrition counseling Behavioral health tools Virtual support groups or community chat Virtual workouts and exercise plans Lab monitoring 4